| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 14.009 | 15.968 | 17.874 | 16.207 | 18.942 | 15.166 | 18.248 | 23.089 | 34.119 | 30.826 |
| Total Income - EUR | 14.127 | 15.997 | 17.874 | 16.207 | 18.942 | 15.166 | 18.248 | 23.091 | 34.266 | 30.827 |
| Total Expenses - EUR | 7.834 | 8.492 | 8.164 | 12.384 | 10.876 | 9.882 | 10.016 | 10.604 | 13.639 | 21.702 |
| Gross Profit/Loss - EUR | 6.293 | 7.505 | 9.711 | 3.823 | 8.066 | 5.284 | 8.232 | 12.486 | 20.627 | 9.125 |
| Net Profit/Loss - EUR | 5.869 | 7.185 | 9.520 | 3.661 | 7.876 | 5.143 | 8.071 | 12.255 | 20.284 | 8.200 |
| Employees | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Genermed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 967 | 650 | 387 | 133 | 1.520 | 868 | 330 | 0 | 31.152 | 27.360 |
| Current Assets | 22.800 | 10.052 | 11.813 | 17.822 | 9.786 | 14.813 | 22.703 | 15.957 | 15.439 | 32.050 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 3.189 | 3.826 | 2.850 | 3.041 | 2.614 | 3.468 | 6.808 | 10.586 | 8.647 | 3.326 |
| Cash | 19.611 | 6.226 | 8.964 | 14.780 | 7.172 | 11.346 | 15.895 | 5.371 | 6.792 | 28.724 |
| Shareholders Funds | 16.392 | 7.238 | 9.573 | 3.712 | 7.927 | 12.920 | 20.704 | 12.304 | 20.332 | 8.248 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 7.375 | 3.464 | 2.627 | 14.242 | 3.379 | 2.762 | 2.329 | 3.653 | 26.259 | 51.161 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Genermed Srl